Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.

Isabel Bergeri,Mairead G Whelan,Harriet Ware,Lorenzo Subissi,Anthony Nardone,Hannah C Lewis,Zihan Li,Xiaomeng Ma,Marta Valenciano,Brianna Cheng,Lubna Al Ariqi,Arash Rashidian,Joseph Okeibunor,Tasnim Azim,Pushpa Wijesinghe,Linh-Vi Le,Aisling Vaughan,Richard Pebody,Andrea Vicari,Tingting Yan,Mercedes Yanes-Lane,Christian Cao,David A Clifton,Matthew P Cheng,Jesse Papenburg,David Buckeridge,Niklas Bobrovitz,Rahul K Arora,Maria D Van Kerkhove

PLoS medicine（2022）

Cited 59|Views49
No score
Abstract
In this study, we observed that global seroprevalence has risen considerably over time and with regional variation; however, over one-third of the global population are seronegative to the SARS-CoV-2 virus. Our estimates of infections based on seroprevalence far exceed reported Coronavirus Disease 2019 (COVID-19) cases. Quality and standardized seroprevalence studies are essential to inform COVID-19 response, particularly in resource-limited regions.
More
Translated text
Key words
systematic review,sars-cov,meta-analysis,population-based
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined